FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1966771714> ?p ?o ?g. }

• W1966771714 endingPage "1673" @default.
• W1966771714 startingPage "1663" @default.
• W1966771714 abstract "Although 1 microg/ml of 17beta-estradiol (E2) is often used in routine in vitro maturation (IVM) and in vitro fertilization (IVF), its effect remains controversial. The objective of our study was to investigate the effects of E2 on bovine oocyte IVM and subsequent embryo development, using a defined medium. Bovine cumulus oocyte complexes (COCs), aspirated from 2 to 8 mm follicles of slaughterhouse ovaries, were matured in TCM199 in the presence of 1 microg/ml E2 with or without 0.05 IU/ml recombinant hFSH. Cultures without E2, FSH or both served as controls. COCs were matured for 22 h at 39 degrees C in a humidified atmosphere of 5% CO2 in air. To investigate the effect of E2 with and without FSH on nuclear maturation, COCs were fixed after maturation and the nuclear stage was assessed following DAPI staining. Similarly, denuded oocytes (DO) were matured in the presence of E2 and the nuclear stage assessed after 22 h. To investigate the effect of E2 with and without FSH during IVM on subsequent embryo development, in vitro matured COCs were fertilized in vitro and after removal of the cumulus cells, the presumed zygotes were cocultured on BRL monolayer for 11 days. At Day 4, the number of cleaved embryos, and at Days 9 and 11, the number of blastocysts, were assessed. Addition of 1 microg/ml E2 to TCM199 significantly decreased the percentage of Metaphase II (MII) compared to control (56.3 and 74.0%, respectively), and increased the percentage of nuclear aberrations compared to control (13.3 and 2.1%, respectively). The negative effect of E2 on nuclear maturation was stronger when DO were matured; 25.1 and 60.0% of the oocytes reached MII stage for the E2 and control groups, respectively. When COCs were matured in TCM199 supplemented with FSH, the addition of 1 microg/ml E2 did not influence the proportion of MII oocytes, although a higher percentage of nuclear aberrations as compared to control was observed. Presence of E2 during IVM also decreased the blastocyst rate (14.4 and 10.0% for control and E2 groups, respectively). However, when FSH was present, the addition of E2 had no effect on the cleavage rate and blastocyst formation (20.3 and 21.7% for control and E2 groups, respectively). In conclusion, supplementation of 1 microg/ml E2 to a serum free maturation medium negatively affects bovine oocyte nuclear maturation and subsequent embryo development. Although these effects are attenuated in the presence of FSH, we strongly suggest omission of E2 in routine maturation protocols of bovine oocytes." @default.
• W1966771714 created "2016-06-24" @default.
• W1966771714 creator A5008726098 @default.
• W1966771714 creator A5056154641 @default.
• W1966771714 creator A5087119375 @default.
• W1966771714 date "2002-12-01" @default.
• W1966771714 modified "2023-10-17" @default.
• W1966771714 title "Effect of 17β-estradiol on the in vitro maturation of bovine oocytes" @default.
• W1966771714 cites W1968333140 @default.
• W1966771714 cites W1971123142 @default.
• W1966771714 cites W1971438031 @default.
• W1966771714 cites W1979423444 @default.
• W1966771714 cites W2004069955 @default.
• W1966771714 cites W2005364262 @default.
• W1966771714 cites W2008429408 @default.
• W1966771714 cites W2010114398 @default.
• W1966771714 cites W2015366217 @default.
• W1966771714 cites W2017662614 @default.
• W1966771714 cites W2029066381 @default.
• W1966771714 cites W2031167987 @default.
• W1966771714 cites W2037457080 @default.
• W1966771714 cites W2051038137 @default.
• W1966771714 cites W2073181635 @default.
• W1966771714 cites W2078934212 @default.
• W1966771714 cites W2086589603 @default.
• W1966771714 cites W2096520379 @default.
• W1966771714 cites W2137359525 @default.
• W1966771714 cites W2149025838 @default.
• W1966771714 cites W2152012987 @default.
• W1966771714 cites W2170008785 @default.
• W1966771714 doi "https://doi.org/10.1016/s0093-691x(02)01082-8" @default.
• W1966771714 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12472137" @default.
• W1966771714 hasPublicationYear "2002" @default.
• W1966771714 type Work @default.
• W1966771714 sameAs 1966771714 @default.
• W1966771714 citedByCount "55" @default.
• W1966771714 countsByYear W19667717142012 @default.
• W1966771714 countsByYear W19667717142013 @default.
• W1966771714 countsByYear W19667717142014 @default.
• W1966771714 countsByYear W19667717142015 @default.
• W1966771714 countsByYear W19667717142016 @default.
• W1966771714 countsByYear W19667717142017 @default.
• W1966771714 countsByYear W19667717142018 @default.
• W1966771714 countsByYear W19667717142019 @default.
• W1966771714 countsByYear W19667717142020 @default.
• W1966771714 countsByYear W19667717142021 @default.
• W1966771714 countsByYear W19667717142022 @default.
• W1966771714 crossrefType "journal-article" @default.
• W1966771714 hasAuthorship W1966771714A5008726098 @default.
• W1966771714 hasAuthorship W1966771714A5056154641 @default.
• W1966771714 hasAuthorship W1966771714A5087119375 @default.
• W1966771714 hasConcept C105702510 @default.
• W1966771714 hasConcept C16685009 @default.
• W1966771714 hasConcept C185592680 @default.
• W1966771714 hasConcept C196843134 @default.
• W1966771714 hasConcept C202751555 @default.
• W1966771714 hasConcept C2775966511 @default.
• W1966771714 hasConcept C2776690073 @default.
• W1966771714 hasConcept C2778177303 @default.
• W1966771714 hasConcept C512716672 @default.
• W1966771714 hasConcept C55493867 @default.
• W1966771714 hasConcept C71924100 @default.
• W1966771714 hasConcept C86803240 @default.
• W1966771714 hasConcept C87073359 @default.
• W1966771714 hasConcept C88972607 @default.
• W1966771714 hasConcept C95444343 @default.
• W1966771714 hasConceptScore W1966771714C105702510 @default.
• W1966771714 hasConceptScore W1966771714C16685009 @default.
• W1966771714 hasConceptScore W1966771714C185592680 @default.
• W1966771714 hasConceptScore W1966771714C196843134 @default.
• W1966771714 hasConceptScore W1966771714C202751555 @default.
• W1966771714 hasConceptScore W1966771714C2775966511 @default.
• W1966771714 hasConceptScore W1966771714C2776690073 @default.
• W1966771714 hasConceptScore W1966771714C2778177303 @default.
• W1966771714 hasConceptScore W1966771714C512716672 @default.
• W1966771714 hasConceptScore W1966771714C55493867 @default.
• W1966771714 hasConceptScore W1966771714C71924100 @default.
• W1966771714 hasConceptScore W1966771714C86803240 @default.
• W1966771714 hasConceptScore W1966771714C87073359 @default.
• W1966771714 hasConceptScore W1966771714C88972607 @default.
• W1966771714 hasConceptScore W1966771714C95444343 @default.
• W1966771714 hasFunder F4320320300 @default.
• W1966771714 hasIssue "9" @default.
• W1966771714 hasLocation W19667717141 @default.
• W1966771714 hasLocation W19667717142 @default.
• W1966771714 hasOpenAccess W1966771714 @default.
• W1966771714 hasPrimaryLocation W19667717141 @default.
• W1966771714 hasRelatedWork W1990334492 @default.
• W1966771714 hasRelatedWork W2005764940 @default.
• W1966771714 hasRelatedWork W2166971475 @default.
• W1966771714 hasRelatedWork W2195810901 @default.
• W1966771714 hasRelatedWork W2349296746 @default.
• W1966771714 hasRelatedWork W2364870984 @default.
• W1966771714 hasRelatedWork W2389182588 @default.
• W1966771714 hasRelatedWork W2617150033 @default.
• W1966771714 hasRelatedWork W4205975727 @default.
• W1966771714 hasRelatedWork W4379599493 @default.
• W1966771714 hasVolume "58" @default.

• next